Lexaria Bioscience (LEXX) Debt/Equity Ratio: History & Chart

Lexaria Bioscience Corp.(LEXX)

Biotechnology · Kelowna, BC

$3.16+0.38 (+13.90%)

Delayed quote: Oct 6, 2026, 3:24 PM EDT

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting the bioavailability of compounds such as cannabinoids and nicotine by 5 to 10 times, and in some cannabinoid applications, by as much as 27 times, when compared to standard formulations. DehydraTECH also drastically cuts the time of onset from hours to mere minutes and effectively neutralizes unpleasant tastes. Beyond its established uses, the technology is currently under evaluation for its potential application with orally administered antiviral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and various other compounds. A notable feature of DehydraTECH is its capacity to facilitate the passage of drugs across the blood-brain barrier. The company operates a licensed internal research facility and holds a substantial intellectual property portfolio, comprising 23 granted patents and roughly 50 pending patent applications globally. Founded in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.

Kelowna, BC

7 employees

www.lexariabioscience.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Richard C. Christopher

View full financials

LEXX Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

0.02

DEBT TO EQUITY RATIO AVG TTM

0.02

DEBT TO EQUITY RATIO AVG 3Y

0.03

DEBT TO EQUITY RATIO AVG 5Y

0.02

DEBT TO EQUITY RATIO AVG 10Y

0.01

DEBT TO EQUITY RATIO AVG 15Y

0.03

DEBT TO EQUITY RATIO AVG 20Y

0.18

CURRENT VS TTM AVG

-17.49%

CURRENT VS 3Y AVG

-28.06%

CURRENT VS 5Y AVG

+18.59%

CURRENT VS 10Y AVG

+38.16%

CURRENT VS 15Y AVG

-33.56%

CURRENT VS 20Y AVG

-89.84%

SECTOR MEDIAN · HEALTHCARE

0.11

median of 774 covered companies

CURRENT VS SECTOR MEDIAN

-83.36%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
Lexaria Bioscience Corp. (LEXX)	$5.21M	0.02	0.02	0.03	0.02
Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›	$5.12M	4.80	6.38	6.38	6.38
Lunai Bioworks Inc. (LNAI)vs ›	$5.19M	N/A	0.07	0.07	0.07
Imunon, Inc. (IMNN)vs ›	$5.04M	1.87	0.21	0.18	0.20
Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›	$5.06M	1.57	0.64	1.33	1.33
Gelteq Limited Ordinary Shares (GELS)vs ›	$5.28M	0.36	0.26	0.18	0.25
Alzamend Neuro Inc (ALZN)vs ›	$5.23M	0.00	0.00	0.00	0.03
Pulmatrix, Inc. (PULM)vs ›	$5.28M	0.00	0.00	0.13	0.11
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.31M	0.33	0.21	0.27	0.18
Soligenix, Inc. (SNGX)vs ›	$5.35M	0.05	0.21	0.61	1.11

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

Lexaria Bioscience Corp. (LEXX)

$5.21M

0.02

0.03

0.02

Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›

$5.12M

4.80

6.38

Lunai Bioworks Inc. (LNAI)vs ›

$5.19M

N/A

0.07

Imunon, Inc. (IMNN)vs ›

$5.04M

1.87

0.21

0.18

0.20

Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›

$5.06M

1.57

0.64

1.33

Gelteq Limited Ordinary Shares (GELS)vs ›

$5.28M

0.36

0.26

0.18

0.25

Alzamend Neuro Inc (ALZN)vs ›

$5.23M

0.00

0.03

Pulmatrix, Inc. (PULM)vs ›

$5.28M

0.00

0.13

0.11

Intelligent Bio Solutions Inc. (INBS)vs ›

$5.31M

0.33

0.21

0.27

0.18

Soligenix, Inc. (SNGX)vs ›

$5.35M

0.05

0.21

0.61

1.11

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Lexaria Bioscience Corp. (LEXX)?

The debt to equity ratio for LEXX stock is 0.02.

Is Lexaria Bioscience Corp.'s debt to equity ratio high or low?

The debt to equity ratio of 0.02 is 19% above its 5-year average of 0.02, near the low end of its 5-year range (0.01–0.05).

What is the TTM average debt to equity ratio for Lexaria Bioscience Corp. (LEXX)?

The TTM average debt to equity ratio for LEXX stock is 0.02.

What is the 3Y average debt to equity ratio for Lexaria Bioscience Corp. (LEXX)?

The 3Y average debt to equity ratio for LEXX stock is 0.03.

What is the 5Y average debt to equity ratio for Lexaria Bioscience Corp. (LEXX)?

The 5Y average debt to equity ratio for LEXX stock is 0.02.

What is the 10Y average debt to equity ratio for Lexaria Bioscience Corp. (LEXX)?

The 10Y average debt to equity ratio for LEXX stock is 0.01.

What is the 15Y average debt to equity ratio for Lexaria Bioscience Corp. (LEXX)?

The 15Y average debt to equity ratio for LEXX stock is 0.03.

What is the 20Y average debt to equity ratio for Lexaria Bioscience Corp. (LEXX)?

The 20Y average debt to equity ratio for LEXX stock is 0.18.

DATE	DEBT TO EQUITY RATIO
2026-05-31	0.02
2026-02-28	0.01
2025-11-30	0.02
2025-08-31	0.04
2025-05-31	0.02
2025-02-28	0.02
2024-11-30	0.01
2024-08-31	0.02
2024-05-31	0.01
2024-02-29	0.02
2023-11-30	0.04
2023-08-31	0.05
2023-05-31	0.04
2023-02-28	0.01
2022-11-30	0.01
2022-08-31	0.01
2022-05-31	0.01
2022-02-28	0.01
2021-11-30	0.01
2021-08-31	0.01
2021-05-31	0.01
2021-02-28	0.01
2020-11-30	0.08
2020-08-31	0.06
2020-05-31	0.01
2020-02-29	0.00
2019-11-30	0.00
2019-08-31	0.00
2019-05-31	0.00
2019-02-28	0.00
2018-11-30	0.00
2018-08-31	0.00
2018-05-31	0.00
2018-02-28	0.00
2017-11-30	0.00
2017-08-31	0.00
2017-05-31	0.01
2017-02-28	0.07
2016-11-30	0.06
2016-08-31	0.17
2016-05-31	0.37
2016-02-29	0.00
2015-11-30	0.00
2015-08-31	0.00
2015-05-31	0.00
2015-02-28	0.00
2014-11-30	0.00
2014-07-31	0.23
2014-04-30	0.24
2014-01-31	0.63
2013-10-31	0.61
2013-07-31	0.58
2013-04-30	0.61
2013-01-31	0.64
2012-10-31	0.68
2012-07-31	0.69
2012-04-30	0.70
2012-01-31	0.61
2011-10-31	0.51
2011-07-31	0.58
2011-04-30	0.76
2011-01-31	0.72
2010-10-31	0.46
2010-07-31	0.41
2010-04-30	0.42
2010-01-31	0.34
2009-10-31	0.34
2009-07-31	0.31
2009-04-30	0.34
2009-01-31	0.30
2008-10-31	0.36
2008-07-31	0.24
2008-04-30	0.25
2008-01-31	0.22
2007-10-31	0.01
2007-07-31	0.19
2007-04-30	0.02
2007-01-31	0.00
2006-10-31	2.82
2006-07-31	0.00
2006-04-30	0.00
2006-01-31	0.00

DATE

DEBT TO EQUITY RATIO

2026-05-31

0.02

2026-02-28

0.01

2025-11-30

0.02

2025-08-31

0.04

2025-05-31

0.02

2025-02-28

0.02

2024-11-30

0.01

2024-08-31

0.02

2024-05-31

0.01

2024-02-29

0.02

2023-11-30

0.04

2023-08-31

0.05

2023-05-31

0.04

2023-02-28

0.01

2022-11-30

0.01

2022-08-31

0.01

2022-05-31

0.01

2022-02-28

0.01

2021-11-30

0.01

2021-08-31

0.01

2021-05-31

0.01

2021-02-28

0.01

2020-11-30

0.08

2020-08-31

0.06

2020-05-31

0.01

2020-02-29

0.00

2019-11-30

0.00

2019-08-31

0.00

2019-05-31

0.00

2019-02-28

0.00

2018-11-30

0.00

2018-08-31

0.00

2018-05-31

0.00

2018-02-28

0.00

2017-11-30

0.00

2017-08-31

0.00

2017-05-31

0.01

2017-02-28

0.07

2016-11-30

0.06

2016-08-31

0.17

2016-05-31

0.37

2016-02-29

0.00

2015-11-30

0.00

2015-08-31

0.00

2015-05-31

0.00

2015-02-28

0.00

2014-11-30

0.00

2014-07-31

0.23

2014-04-30

0.24

2014-01-31

0.63

2013-10-31

0.61

2013-07-31

0.58

2013-04-30

0.61

2013-01-31

0.64

2012-10-31

0.68

2012-07-31

0.69

2012-04-30

0.70

2012-01-31

0.61

2011-10-31

0.51

2011-07-31

0.58

2011-04-30

0.76

2011-01-31

0.72

2010-10-31

0.46

2010-07-31

0.41

2010-04-30

0.42

2010-01-31

0.34

2009-10-31

0.34

2009-07-31

0.31

2009-04-30

0.34

2009-01-31

0.30

2008-10-31

0.36

2008-07-31

0.24

2008-04-30

0.25

2008-01-31

0.22

2007-10-31

0.01

2007-07-31

0.19

2007-04-30

0.02

2007-01-31

0.00

2006-10-31

2.82

2006-07-31

0.00

2006-04-30

0.00

2006-01-31

0.00

Debt to Equity Ratio: 0.02

LEXX Debt to Equity Ratio

LEXX Average Debt to Equity Ratio Chart

LEXX Current vs Average Debt to Equity Ratio Chart

LEXX Debt to Equity Ratio Metrics

LEXX Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

LEXX Debt to Equity Ratio History

Related Metrics